{"id":"W2152127926","doi":"10.1186/1756-8722-7-1","title":"Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors","year":2014,"lang":"en","type":"article","venue":"Journal of Hematology & Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":190,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Cancer Research UK; National Cancer Institute; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Royal Marsden NHS Foundation Trust","keywords":"Medicine; Docetaxel; Carboplatin; Rash; Internal medicine; Paclitaxel; Erlotinib; Nausea; Febrile neutropenia; Pharmacology; Oncology; Neutropenia; Chemotherapy; Cisplatin; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008488764,0.0003000197,0.001205778,0.0001581401,0.00007134894,0.000008629167,0.0005528922,0.0004376812,0.00004037027],"category_scores_gemma":[0.00102568,0.0001882806,0.0002224449,0.000225909,0.0004444752,0.00001800534,0.0001464424,0.0005224912,0.000002160702],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00015335,"about_ca_system_score_gemma":0.001145798,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001250142,"about_ca_topic_score_gemma":0.0001895912,"domain_scores_codex":[0.9968957,0.0006155442,0.001326094,0.0003480046,0.0003411799,0.0004734803],"domain_scores_gemma":[0.9969441,0.000235392,0.00180349,0.0004516267,0.0004306789,0.0001347124],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6376985,0.01218309,0.07999736,0.0003777155,0.001537305,0.0003896045,0.001291063,0.003211905,0.2300812,0.0007178565,0.01087222,0.02164215],"study_design_scores_gemma":[0.5013989,0.1210176,0.004110197,0.0005700686,0.0004491488,0.001410897,0.0004029663,0.0001432284,0.3337444,0.0003746965,0.03542234,0.0009556052],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968151,0.0003019453,0.0001783825,0.0004028322,0.001437458,0.0005609189,0.00001772023,0.000005565983,0.0002800096],"genre_scores_gemma":[0.9975426,0.00002011043,0.0015152,0.000391602,0.0003906559,0.00002766951,0.00001075891,0.00003922367,0.00006215405],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1362996,"threshold_uncertainty_score":0.7677862,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01163486206297069,"score_gpt":0.3165527604870124,"score_spread":0.3049178984240417,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}